Luca Benatti
Vermögen: 4 506 $ am 31.05.2026
Vermögen: 4 506 $ am 31.05.2026
Luca Benatti was the founder of Newron Pharmaceuticals SpA, founded in 1998, and served as Independent Non-Executive Director from 2012 to 2026.
Current jobs include Chief Executive Officer & Director at TES Pharma SRL since 2024, Chairman at Italian Angels For Biotech, Independent Director at Metis Precision Medicine Sb Srl, Director at CaSRevolution Srl, and Principal at The European Association for Bioindustries.
Former jobs include Chief Executive Officer & Director at Quince Therapeutics SpA from 2012 to 2023, Vice Chairman at Assobiotec, Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2023, Independent Director at Quince Therapeutics, Inc. from 2023 to 2026, and Head-Molecular Neurobiology Department at Pharmacia & Upjohn SpA in 1998.
Education includes undergraduate studies at the University of Milan.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.12.2025 | 3’918 ( 0.02% ) | 4 506 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
The European Association for Bioindustries | Corporate Officer/Principal | 30.04.2010 |
Metis Precision Medicine Sb Srl
Metis Precision Medicine Sb Srl Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies | Direktor/Vorstandsmitglied | - |
Italian Angels For Biotech
Italian Angels For Biotech Investment ManagersFinance IAB invests in companies located in Italy. The firm target companies operating in the field of life sciences. It provides financing for early stage capital requirements with investment size ranging from EUR 0.005 - 0.1 million. It also takes board seat and acts as lead investor. | Vorsitzender | - |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology Provides vitro diagnostics | Vorstandsvorsitzender | 01.02.2024 |
CaSRevolution SRL
CaSRevolution SRL BiotechnologyHealth Technology Provides therapies services for neurodegenerative diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Gründer | 23.04.2026 |
| QUINCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 30.01.2026 |
| INTERCEPT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.11.2023 |
EryDel SpA
EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Vorstandsvorsitzender | 01.09.2023 |
| ░░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EryDel SpA
EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Health Technology |
The European Association for Bioindustries | |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Commercial Services |
Pharmacia & Upjohn SpA | |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology Provides vitro diagnostics | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Italian Angels For Biotech
Italian Angels For Biotech Investment ManagersFinance IAB invests in companies located in Italy. The firm target companies operating in the field of life sciences. It provides financing for early stage capital requirements with investment size ranging from EUR 0.005 - 0.1 million. It also takes board seat and acts as lead investor. | Finance |
Metis Precision Medicine Sb Srl
Metis Precision Medicine Sb Srl Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies | Commercial Services |
CaSRevolution SRL
CaSRevolution SRL BiotechnologyHealth Technology Provides therapies services for neurodegenerative diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen